Franklin S. Edmonds Jr.
Known title: DirectorCIK: 0001845216
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.
Transaction History
| ATKR | ▲ Buy | Grant | 10 | $0 | 8/28/2026 | View on chart |
| ATKR | ▲ Buy | Grant | 11 | $0 | 5/29/2026 | View on chart |
| ATKR | ▲ Buy | Grant | 14 | $0 | 2/27/2026 | View on chart |
| ATKR | ▲ Buy | Grant | 2,808 | $0 | 1/29/2026 | View on chart |
| MDAI | ▲ Buy | Option Exercise | 20,000 | $0 | 9/11/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
ATKR featured among industrials stocks called worth investigating
A recent Yahoo Finance roundup named Atkore as one of the industrials stocks worth investigating, while two other companies in the same sector were described as underwhelming. Being singled out as a company that deserves a closer look is a notable distinction in a sector-themed screen. The stock is currently trading near the top of its 52-week range of $53.75 to $94.14, and the average analyst price target sits at $93.50, in line with recent price levels.
ATKR featured among industrials stocks called worth investigating. A recent Yahoo Finance roundup named Atkore as one of the industrials stocks worth investigating, while two other companies in the same sector were described as underwhelming. Being singled out as a company that deserves a closer look is a notable distinction in a sector-themed screen. The stock is currently trading near the top of its 52-week range of $53.75 to $94.14, and the average analyst price target sits at $93.50, in line with recent price levels.